-
-
-
-
-
-
-
B.Riley on Agenus Inc. (AGEN) Amid 8pct Gain: 'The stock remains deeply undervalued at a near-zero EV'
-
-
-
-
-
-
-
Agenus publishes ovarian cancer treatment results in medical journal
-
-
-
-
-
-
-
Agenus (AGEN) Misses Q2 EPS by 100c
-
-
-
-
-
-
-
Agenus (AGEN) to Sell U.S. manufacturing facilities to Zydus Lifesciences
-
-
-
-
-
-
-
Agenus (AGEN) Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas
-
-
-
-
-
-
-
Agenus (AGEN) Presents Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas
-
-
-
-
-
-
-
Baird Downgrades Agenus Inc. (AGEN) to Neutral
-
433,162 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

